{"id":"https://openalex.org/W183023973","doi":null,"title":"New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).","display_name":"New approach in the treatment of T2DM and metabolic syndrome (focus on a novel insulin sensitizer).","publication_year":2006,"publication_date":"2006-07-01","ids":{"openalex":"https://openalex.org/W183023973","mag":"183023973","pmid":"https://pubmed.ncbi.nlm.nih.gov/17119268"},"language":"en","primary_location":{"id":"pmid:17119268","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17119268","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta medica Indonesiana","raw_type":"Journal Article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5063812781","display_name":"Askandar Tjokroprawiro","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I205133468","display_name":"Universitas Airlangga","ror":"https://ror.org/04ctejd88","country_code":"ID","type":"education","lineage":["https://openalex.org/I205133468"]}],"countries":["ID"],"is_corresponding":true,"raw_author_name":"Askandar Tjokroprawiro","raw_affiliation_strings":["Diabetes and Nutrition Center, Dr. Soetomo Teaching Hospital-Airlangga University, Faculty of Medicine, Surabaya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Diabetes and Nutrition Center, Dr. Soetomo Teaching Hospital-Airlangga University, Faculty of Medicine, Surabaya","institution_ids":["https://openalex.org/I205133468"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5063812781"],"corresponding_institution_ids":["https://openalex.org/I205133468"],"apc_list":null,"apc_paid":null,"fwci":0.3368,"has_fulltext":false,"cited_by_count":28,"citation_normalized_percentile":{"value":0.49136272,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"38","issue":"3","first_page":"160","last_page":"6"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.003100000089034438,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10027","display_name":"Diabetes, Cardiovascular Risks, and Lipoproteins","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.9259999990463257},{"id":"https://openalex.org/keywords/metabolic-syndrome","display_name":"metabolic syndrome","score":0.9800000190734863},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.7289999723434448},{"id":"https://openalex.org/keywords/insulin-sensitizers","display_name":"insulin sensitizers","score":0.8159999847412109},{"id":"https://openalex.org/keywords/thiazolidinediones","display_name":"thiazolidinediones","score":0.9279999732971191},{"id":"https://openalex.org/keywords/ppargamma","display_name":"PPAR\u03b3","score":0.6740000247955322},{"id":"https://openalex.org/keywords/pparalpha","display_name":"PPAR\u03b1","score":0.781000018119812},{"id":"https://openalex.org/keywords/ppardelta","display_name":"PPAR\u03b4","score":0.9359999895095825},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":0.8410000205039978},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/cardiovascular-risk","display_name":"cardiovascular risk","score":0.6610000133514404},{"id":"https://openalex.org/keywords/homa-ir","display_name":"HOMA-IR","score":0.7279999852180481},{"id":"https://openalex.org/keywords/homa-beta","display_name":"HOMA-\u03b2","score":0.6869999766349792},{"id":"https://openalex.org/keywords/coronary-artery-disease","display_name":"coronary artery disease","score":0.6060000061988831},{"id":"https://openalex.org/keywords/endothelial-dysfunction","display_name":"endothelial dysfunction","score":0.6880000233650208},{"id":"https://openalex.org/keywords/dyslipidemia","display_name":"dyslipidemia","score":0.7599999904632568},{"id":"https://openalex.org/keywords/hyperuricemia","display_name":"hyperuricemia","score":0.7149999737739563}],"concepts":[{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.872562825679779},{"id":"https://openalex.org/C2780578515","wikidata":"https://www.wikidata.org/wiki/Q657193","display_name":"Metabolic syndrome","level":3,"score":0.7930970191955566},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.7764869332313538},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.7755661010742188},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7097283005714417},{"id":"https://openalex.org/C2780988686","wikidata":"https://www.wikidata.org/wiki/Q14375936","display_name":"Hyperinsulinemia","level":4,"score":0.6310753226280212},{"id":"https://openalex.org/C112446052","wikidata":"https://www.wikidata.org/wiki/Q422579","display_name":"Insulin receptor","level":4,"score":0.4980170726776123},{"id":"https://openalex.org/C2778096610","wikidata":"https://www.wikidata.org/wiki/Q1476525","display_name":"Dyslipidemia","level":3,"score":0.48652997612953186},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.48103052377700806},{"id":"https://openalex.org/C167400880","wikidata":"https://www.wikidata.org/wiki/Q3454539","display_name":"Liver X receptor","level":5,"score":0.4647729992866516},{"id":"https://openalex.org/C3018667095","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Glucose homeostasis","level":4,"score":0.4197724461555481},{"id":"https://openalex.org/C2780972559","wikidata":"https://www.wikidata.org/wiki/Q550061","display_name":"Endothelial dysfunction","level":2,"score":0.4190451502799988},{"id":"https://openalex.org/C171089720","wikidata":"https://www.wikidata.org/wiki/Q193583","display_name":"Adipose tissue","level":2,"score":0.41044241189956665},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.3539784550666809},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.21400117874145508},{"id":"https://openalex.org/C63932345","wikidata":"https://www.wikidata.org/wiki/Q422500","display_name":"Nuclear receptor","level":4,"score":0.17950525879859924},{"id":"https://openalex.org/C86339819","wikidata":"https://www.wikidata.org/wiki/Q407384","display_name":"Transcription factor","level":3,"score":0.12221786379814148},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D003924","descriptor_name":"Diabetes Mellitus, Type 2","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D007004","descriptor_name":"Hypoglycemic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D024821","descriptor_name":"Metabolic Syndrome","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:17119268","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17119268","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Acta medica Indonesiana","raw_type":"Journal Article"},{"id":"mag:183023973","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17119268","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9907000064849854,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":28,"referenced_works":["https://openalex.org/W42853999","https://openalex.org/W1566733175","https://openalex.org/W1588222095","https://openalex.org/W1608611896","https://openalex.org/W1964562381","https://openalex.org/W1967713685","https://openalex.org/W1976621212","https://openalex.org/W1977004017","https://openalex.org/W1979820286","https://openalex.org/W1987522063","https://openalex.org/W2015279471","https://openalex.org/W2023097850","https://openalex.org/W2030510579","https://openalex.org/W2044816554","https://openalex.org/W2047850005","https://openalex.org/W2074630167","https://openalex.org/W2085487827","https://openalex.org/W2096387670","https://openalex.org/W2109607186","https://openalex.org/W2111251212","https://openalex.org/W2124838987","https://openalex.org/W2125916336","https://openalex.org/W2134913680","https://openalex.org/W2152598925","https://openalex.org/W2158330544","https://openalex.org/W2338175593","https://openalex.org/W2409762397","https://openalex.org/W2417796581"],"related_works":["https://openalex.org/W79782691","https://openalex.org/W80762741","https://openalex.org/W2162463137","https://openalex.org/W2365629188","https://openalex.org/W2159453872","https://openalex.org/W1975357394","https://openalex.org/W4254128803","https://openalex.org/W2050158436","https://openalex.org/W1539062345","https://openalex.org/W2364703733"],"abstract_inverted_index":{"Peroxisome":[0],"Proliferator-Activate":[1],"Receptors":[2],"(PPARs)":[3],"are":[4,20,237,246],"transcription":[5],"factors":[6,116],"belonging":[7],"to":[8,92,176,209,282,285,336],"the":[9,24,32,66,98,101,124,177,192,211,286,327,402],"nuclear":[10],"receptor":[11],"superfamily.":[12],"The":[13,81,171,243],"three":[14],"PPARs":[15],"(alpha,":[16],"beta/delta,":[17],"and":[18,42,57,62,78,90,113,121,126,166,169,181,198,229,271,279,300,317,326,332,354,373,390,399,401,410],"gamma)":[19],"distributed":[21],"differently":[22],"in":[23,31,37,54,65,88,95,191,216,241,260,370,377,397],"different":[25],"organs.":[26],"PPARalpha":[27],"is":[28,47,206],"most":[29,207],"common":[30],"liver,":[33],"but":[34,346],"also":[35,320,411],"found":[36,53],"kidney,":[38],"gut,":[39],"skeletal":[40],"muscle":[41],"adipose":[43],"tissue,":[44],"while":[45],"PPARbeta/delta,":[46],"fairly":[48],"ubiquitous;":[49],"it":[50,280],"may":[51,174,310],"be":[52,93,275,283],"body":[55],"tissues":[56],"brain":[58],"(for":[59],"myelination":[60],"process":[61],"lipid":[63],"metabolism":[64],"brain).":[67],"PPARgamma":[68,74,76,79,273,319,389],"has":[69,118,219],"3":[70],"isoforms,":[71],"such":[72,127,195,314],"as":[73,315,359],"1,":[75],"2,":[77],"3.":[80],"syndrome-X":[82,173],"was":[83],"firstly":[84],"coined":[85],"by":[86,97,123,227,277,303,395],"Reaven":[87],"1988":[89],"then":[91],"provided":[94],"1999":[96],"name":[99],":":[100],"metabolic":[102,105,111,172,378],"syndrome-X.":[103],"This":[104],"syndrome":[106,197],"represents":[107],"a":[108,128,196,360,383],"\"Cluster\"":[109],"of":[110,179,194,202,288,306,324,388,392,404,407],"disorders":[112],"cardiovascular":[114,199,213,374],"risk":[115],"which":[117],"been":[119,220],"collected":[120],"summarized":[122],"author":[125],"cluster":[129],"includes:":[130],"insulin":[131,186,312,328,338,393,405],"resistance/hyperinsulinemia,":[132],"central":[133],"obesity,":[134],"glucose":[135,353],"intolerance/DM,":[136],"atherogenic":[137],"dyslipidemia":[138],"(increase":[139,152],"TG,":[140],"decrease":[141,296,415],"HDL-cholesterol,":[142],"increase":[143,145,154,156,158,160,292,294,298,337,412],"Apo-B,":[144],"small":[146],"dense":[147],"LDL),":[148],"hypertension,":[149],"prothrombotic":[150],"state":[151],"PAI-1,":[153],"F-VII,":[155],"fibrinogen,":[157],"vWF,":[159],"adhesion":[161],"molecules),":[162],"endothelial":[163],"dysfunction,":[164],"hyperuricemia,":[165],"increased":[167,322],"hsC-RP":[168],"cytokines.":[170],"lead":[175,335],"development":[178],"T2DM":[180],"coronary":[182],"heart":[183],"disease":[184],"(CHD);":[185],"resistance":[187],"plays":[188],"pivotal":[189],"roles":[190],"progression":[193],"diseases.":[200],"Improvement":[201],"Insulin":[203,224,231,247],"Resistance,":[204],"therefore,":[205],"likely":[208],"reduce":[210],"high":[212],"event":[214],"rate":[215],"T2DM.":[217,242],"It":[218],"generally":[221],"accepted":[222],"that":[223,266,309],"Resistance":[225],"(detected":[226],"HOMA-R)":[228],"Acute":[230],"Response":[232],"=":[233,251,254],"AIR":[234],"(by":[235],"HOMA-B)":[236],"both":[238,269,333],"usually":[239],"present":[240],"Thiazolidinedions":[244],"(TZDs)":[245],"Sensitizers":[248],"(e.g":[249,344],"Rosiglitazone":[250],"ROS,":[252],"Pioglitazone":[253],"PIO)":[255],"introduced":[256],"into":[257],"clinical":[258,262],"practice":[259],"1997;":[261],"evidence":[263,381],"data":[264],"showed":[265],"TZDs":[267,278],"improved":[268],"HOMA-R,":[270],"HOMA-B.":[272],"can":[274],"activated":[276],"appears":[281],"fundamental":[284],"pathophysiology":[287],"diabetes":[289,371],"mellitus":[290,372],"i.e":[291],"GLUT-4,":[293,299],"glucokinase,":[295],"PEPCK,":[297],"decreases":[301],"production":[302,323],"fat":[304],"cell":[305],"several":[307],"mediators":[308],"cause":[311],"resistance,":[313],"TNFalpha":[316,398],"resistin.":[318,416],"mediates":[321],"Adiponectin":[325],"signaling":[329],"intermediate":[330],"PI3K,":[331],"actions":[334],"sensitivity.":[339],"A":[340],"\"dual":[341,362],"PPARgamma-PPARalpha":[342,363],"agonists\"":[343],"PIO,":[345,358],"ROS":[347],"poorly":[348],"activate":[349],"PPARalpha)":[350],"might":[351],"lower":[352],"modulate":[355],"lipids.":[356],"Thus,":[357],"stronger":[361],"agonists\",":[364],"shows":[365],"an":[366],"important":[367],"therapeutic":[368],"pathway":[369],"diseases,":[375],"even":[376],"syndrome.":[379],"Current":[380],"suggests":[382],"close":[384],"relationship":[385],"between":[386],"activation":[387],"restoration":[391],"sensitivity":[394],"reductions":[396],"FFAs,":[400],"enhancement":[403],"stimulation":[406],"PI3-K":[408],"Pathway":[409],"adiponectin":[413],"&":[414]},"counts_by_year":[{"year":2023,"cited_by_count":2},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":2},{"year":2019,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":2},{"year":2015,"cited_by_count":3},{"year":2014,"cited_by_count":2},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":3}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}